These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37360582)

  • 1. The Asymmetric Impact of COVID-19: A Novel Approach to Quantifying Financial Distress across Industries.
    Archanskaia E; Canton E; Hobza A; Nikolov P; Simons W
    Eur Econ Rev; 2023 Jun; ():104509. PubMed ID: 37360582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small firms and the COVID-19 insolvency gap.
    Dörr JO; Licht G; Murmann S
    Small Bus Econ (Dordr); 2022; 58(2):887-917. PubMed ID: 38624681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussion of "The Asymmetric Impact of COVID-19: A Novel Approach to Quantifying Financial Distress across Industries".
    Wang X
    Eur Econ Rev; 2023 Aug; 157():104501. PubMed ID: 37346244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 pandemic, firms' responses, and unemployment in the ASEAN-5.
    Ardiyono SK
    Econ Anal Policy; 2022 Dec; 76():337-372. PubMed ID: 36065456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green management, access to credit, and firms' vulnerability to the COVID-19 crisis.
    Aristei D; Gallo M
    Small Bus Econ (Dordr); 2023 Apr; ():1-33. PubMed ID: 38625207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying corporate liquidity and regulatory responses for economic recovery in COVID-19 crises.
    Chang L; Gan X; Mohsin M
    Econ Anal Policy; 2022 Dec; 76():211-225. PubMed ID: 36043124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of corporate insolvency during COVID-19 pandemic. Evidence from France.
    Stef N; Bissieux JJ
    Int Rev Law Econ; 2022 Jun; 70():106063. PubMed ID: 35261416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cash the panacea of the COVID-19 pandemic: Evidence from corporate performance.
    Zheng M
    Financ Res Lett; 2022 Mar; 45():102151. PubMed ID: 35221815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Covid-19 outbreak, corporate financial distress and earnings management.
    Aljughaiman AA; Nguyen TH; Trinh VQ; Du A
    Int Rev Financ Anal; 2023 Jul; 88():102675. PubMed ID: 37144179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining financial distress of the Vietnamese listed firms using accounting-based models.
    Tran T; Nguyen NH; Le BT; Thanh Vu N; Vo DH
    PLoS One; 2023; 18(5):e0284451. PubMed ID: 37220128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating insolvency and business recovery problems in the oil industry: proposal for improvement in Nigeria's insolvency and bankruptcy legal framework.
    Olujobi OJ
    Heliyon; 2021 Feb; 7(2):e06123. PubMed ID: 33659729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COVID-19 pandemic and family business performance.
    Miroshnychenko I; Vocalelli G; De Massis A; Grassi S; Ravazzolo F
    Small Bus Econ (Dordr); 2023 Apr; ():1-29. PubMed ID: 38625269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of COVID-19 on the valuations of non-financial European firms.
    Abbas Rizvi SK; Yarovaya L; Mirza N; Naqvi B
    Heliyon; 2022 Jun; 8(6):e09486. PubMed ID: 35634174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SME viability in the COVID-19 recovery.
    McCann F; McGeever N; Yao F
    Small Bus Econ (Dordr); 2023 Jan; ():1-22. PubMed ID: 38625252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic effect on corporate financial asset holdings: Precautionary or return-chasing?
    Gao H; Wen H; Wang X
    Res Int Bus Finance; 2022 Dec; 62():101750. PubMed ID: 35996462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
    Thi Mai Nguyen L; Le D; Vu KT; Tran TK
    Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does financial transparency substitute corporate governance to improve stock liquidity? Evidence from emerging market of Pakistan.
    Ali S; Zhongxin W; Ali Z; Usman M; Zhuoping Y
    Front Psychol; 2022; 13():1003081. PubMed ID: 36452385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.